ELIZABETH MARTIN: Open Payments
NPI 1073090783 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 86 payments from 20 companies in 2025. Trend: 2023 $803 · 2024 $854 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $249 |
| ABBVIE INC. | 17 | $200 |
| PFIZER INC. | 10 | $196 |
| Lilly USA, LLC | 10 | $180 |
| Novo Nordisk Inc | 9 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $109 |
| Dexcom, Inc. | 1 | $109 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: BREZTRI, MOUNJARO, QULIPTA, XIFAXAN, DEXCOM G7 GSS (161), ZAVZPRET, NURTEC ODT, Ozempic.
Industry payments across KS — which companies pay providers there.
